Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only.
NCT03502356 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 400
Last updated 2018-04-18
Summary
The good standard antibiotic prophylaxis pre elective C S is cefazolin and this study will approve addition of azithromycin to cefazolin will reduce post CS infections more than cefazolin only.
Conditions
- Randomized Controll Trial
Interventions
- DRUG
-
In this group, patients will receive standard antibiotic prophylaxis CEFAZOLIN (at a dose of 1 g) and azithromycin (at a dose of 1g) 2 hours preoperative.
Sponsors & Collaborators
-
Ain Shams University
lead OTHER
Principal Investigators
-
mohamed 20 amar, md · ain shams
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-20
- Primary Completion
- 2018-06-20
- Completion
- 2018-08-20
Countries
- Egypt
Study Locations
More Related Trials
-
Antibiotics for Prevention of SSI in Obese Women Undergoing CS
NCT03736187 ·Status: UNKNOWN ·Phase: NA
-
Does a Preoperative Prophylactic Antibiotic Reduce Surgical Site Infection Following Wire-localized Lumpectomy
NCT04818931 ·Status: COMPLETED ·Phase: NA
-
The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery
NCT01464840 ·Status: COMPLETED
-
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00505258 ·Status: WITHDRAWN ·Phase: PHASE2
-
Duration of Cardiac Antimicrobial Prophylaxis Outcomes Study
NCT05447559 ·Status: RECRUITING ·Phase: PHASE4
-
Pharmacokinetics and Safety of Cefazolin 3gm DUPLEX in Adults
NCT05205486 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Ceftobiprole on Human Intestinal Microflora
NCT00965042 ·Status: COMPLETED ·Phase: PHASE1
-
Prophylactic Antibiotics for Prevention of Wound Complications Following Vulvectomy
NCT00550290 ·Status: COMPLETED ·Phase: PHASE4
-
Cefazolin Versus Antistaphylococcal Penicillins for Methicillin Susceptible Staphylococcus Aureus Bacteremia
NCT07186894 ·Status: ACTIVE_NOT_RECRUITING
-
Vaginal Preparation and Azithromycin to Reduce Post Cesarean Infections
NCT04163679 ·Status: TERMINATED ·Phase: NA
-
Kefazolin Versus Kefazolin Plus Metronidazole to Reduce Postpartum Infection
NCT04792710 ·Status: UNKNOWN ·Phase: PHASE4
-
24 Vs 48 Hours of Cefazolin or Cefuroxime as Prophylaxis
NCT04303390 ·Status: COMPLETED ·Phase: PHASE4
-
Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery
NCT02996656 ·Status: RECRUITING ·Phase: NA
-
Cefazolin PK Study 3g vs 2g
NCT05309304 ·Status: COMPLETED ·Phase: PHASE1
-
Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration
NCT00752882 ·Status: UNKNOWN ·Phase: PHASE2
-
A Randomized, Controlled Trial of the Effectiveness of Perioperative Antibiotics for Reduction of Burn Wound Bacterial Concentration Following Grafting
NCT04516148 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation of Cross-allergies Between Cefazolin and Amoxicillin With Skin Tests and Provocation Test
NCT05605795 ·Status: UNKNOWN
-
Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis
NCT06005168 ·Status: COMPLETED ·Phase: PHASE4
-
Postoperative Antibiotics Following Primary and Secondary Breast Augmentation
NCT04834310 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
NCT01912651 ·Status: RECRUITING ·Phase: PHASE4
-
A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections
NCT07063095 ·Status: RECRUITING ·Phase: PHASE3
-
Safety, Efficacy and Pharmacokinetics of CF-301 vs. Placebo in Addition to Antibacterial Therapy for Treatment of S. Aureus Bacteremia
NCT03163446 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Prophylactic Use of an Antibiotic for Medical Thoracoscopy
NCT02446782 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Colistin Based Antibiotic Therapy
NCT04764058 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2